Brimonidine/timolol

From Food & Medicine Encyclopedia

(Redirected from Combigan)

Brimonidine/Timolol is a combination ophthalmic medication used for the treatment of glaucoma and ocular hypertension. It consists of two active ingredients:

This combination is prescribed for patients who require additional intraocular pressure (IOP) reduction beyond monotherapy.

Mechanism of Action[edit]

The combination of brimonidine and timolol works synergistically to lower intraocular pressure:

Brimonidine (Alpha-2 Agonist)[edit]

Timolol (Beta-Blocker)[edit]

The dual mechanism provides a greater IOP-lowering effect compared to either drug alone.

Indications[edit]

Brimonidine/Timolol is primarily indicated for:

Dosage and Administration[edit]

Contraindications[edit]

Brimonidine/Timolol should not be used in patients with:

Side Effects[edit]

Like all medications, Brimonidine/Timolol may cause side effects, including:

Common Side Effects[edit]

  • Ocular effects:
  • Eye irritation or redness
  • Dry eyes
  • Blurred vision
  • Burning or stinging sensation

Serious Adverse Reactions[edit]

Patients experiencing significant side effects should seek medical attention.

Drug Interactions[edit]

Brimonidine/Timolol may interact with various medications:

Patients should inform their healthcare provider about all medications they are taking.

Special Precautions[edit]

Pregnancy and Breastfeeding[edit]

Use in Pediatric and Geriatric Populations[edit]

Storage and Handling[edit]

See Also[edit]

External Links[edit]





This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.